Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zenas BioPharma (ZBIO) Return on Capital Employed (2024 - 2025)

Zenas BioPharma (ZBIO) has 2 years of Return on Capital Employed data on record, last reported at 0.79% in Q3 2025.

  • For Q3 2025, Return on Capital Employed changed N/A year-over-year to 0.79%; the TTM value through Sep 2025 reached 0.79%, changed N/A, while the annual FY2024 figure was 1.01%, N/A changed from the prior year.
  • Return on Capital Employed reached 0.79% in Q3 2025 per ZBIO's latest filing, down from 0.73% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.5% in Q4 2024 and bottomed at 0.79% in Q3 2025.